Failure to decrease parasympathetic tone during upright tilt predicts a positive tilt-table test
References (30)
The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart
J Am Coll Cardiol
(1983)- et al.
Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study
Am J Cardiol
(1990) - et al.
Isoproterenol induction of vasodepressor-type reaction in vasodepressor-prone persons
Am J Cardiol
(1989) - et al.
Head-upright tilt-table testing in evaluation and management of the malignant vasovagal syndrome
Am J Cardiol
(1992) - et al.
Evaluation of edrophonium as a provocative agent for vasovagal syncope during headup tilt-table testing
Am J Cardiol
(1993) - et al.
Comparision of time and frequency domain-based measures of cardiac parasympathetic activity in Holler recordings after myocardial infarction
Am J Cardiol
(1989) - et al.
Accuracy of assessment of cardiac vagal tone by heart rate variability in normal subjects
Am J Cardiol
(1991) - et al.
Echocardiographic demonstration of decreased left ventricular dimensions and vigorous myocardial contraction during syncope induced by head-up tilt
J Am Coll Cardiol
(1991) - et al.
Catecholamines in vasovagal fainting
J Psychosom Res
(1965) - et al.
Effect of passive tilt on sympathetic and parasympathetic components of heart rate variability in normal subjects
Am J Cardiol
(1989)
Do patients with neurally mediated syncope have augmented vagal tone?
Am J Cardiol
(1993)
Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia
Am J Cardiol
(1990)
Effects of transdermal scopolamine on heart rate variability in normal subjects
Am J Cardiol
(1990)
Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope
J Am Coll Cardiol
(1992)
Syncope: current diagnostic evaluation and management
Ann Intern Med
(1990)
Cited by (0)
This study was supported in part by Grant HL-44747 from the National Institutes of Health, Bethesda, Maryland, and the Michael Wolk Heart Foundation, New York, New York.
This paper was presented in part at the 66th Annual Scientific Session of the American Heart Association in November 1993.
- 1
Dr. Lerman is an Established Investigator of the American Heart Association.
Copyright © 1995 Published by Elsevier Inc.